In a significant policy shift, the WTA has mandated that all players must complete genetic testing to remain eligible for competition on the tour. This requirement is set to take effect immediately and is part of the WTA's efforts to ensure fairness and equal opportunities for all athletes. The new rule comes in anticipation of the 2028 Los Angeles Olympics, where compliance with these testing protocols will be essential for participation. The announcement has sparked discussions among players and stakeholders about the implications of such testing on privacy and competition.